Evidence map›Paper›PMID 38851247›Full record

ArticleOpen heart2024

Population-based disease-group analysis of Spanish excess mortality in the early COVID-19 pandemic period.

Francisco Reyes-Santias, Juan Carlos Reboredo-Nogueira, Rosa Maria Garcia-Alvarez, Sergio Cinza-Sanjurjo, Jose Ramon Gonzalez Juanatey

Abstract read
In one paragraph

Article in Open heart, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Francisco Reyes-SantiasUniversity of Vigo, Vigo, Spain.
Juan Carlos Reboredo-NogueiraUniversity of Santiago de Compostela, Santiago de Compostela, Spain.
Rosa Maria Garcia-AlvarezPreventive Medicine Department, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Sergio Cinza-SanjurjoIDIS, Santiago de Compostela, Spain scinzas@semergen.es.ORCID 0000-0002-4486-2820
Jose Ramon Gonzalez JuanateyCentro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimIncreased mortality during the COVID-19 pandemic is not explained exclusively by COVID-19 infection and its complications. We analysed non-COVID-19 causes of mortality in a population analysis based on data from the Spanish National Institute of Statistics.

methodsUsing monthly mortality data in Spain (January 2010-December 2020), we analysed deaths associated with cancer, blood, endocrine, mental, nervous, cardiovascular, respiratory and digestive diseases and explored the COVID-19 impact using a difference-in-difference strategy. We calculated monthly interannual variations in mortality and computed percentage change in terms of the log of deaths in month

resultsIn 2020 in Spain, mortality increased 17.9% compared with 2019. COVID-19 was the leading cause of death (n=60 358), followed by ischaemic heart disease (n=29 654). Throughout 2020, monthly interannual variations in cardiovascular mortality showed an average upward trend of 1.7%, while digestive, cancer and blood diseases showed a downward trend.

conclusionsDuring the COVID-19 pandemic in Spain in 2020, excess mortality was primarily related to cardiovascular mortality while mortality associated with digestive, cancer and blood diseases was reduced.

Indexed as

Cause of DeathCOVID-19AdultAgedCardiovascular DiseasesFemaleHumansMaleMiddle AgedNeoplasmsPandemicsSARS-CoV-2SpainTime FactorsCOVID-19EpidemiologyPUBLIC HEALTH

Identifiers

PMID38851247
PMCPMC11163686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.